# Propranolol Reactivation Mismatch (PRM) Treatment for PTSD

> **NCT03652922** · PHASE4 · UNKNOWN · sponsor: **Massachusetts General Hospital** · enrollment: 11 (estimated)

## Conditions studied

- Stress Disorders, Post-Traumatic

## Interventions

- **DRUG:** Reactivation Mismatch

## Key facts

- **NCT ID:** NCT03652922
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09
- **Primary completion:** 2019-11
- **Final completion:** 2019-11
- **Target enrollment:** 11 (ESTIMATED)
- **Last updated:** 2018-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03652922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03652922, "Propranolol Reactivation Mismatch (PRM) Treatment for PTSD". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03652922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*